Loyola University School of Medicine, USA
* Corresponding author

Article Main Content

is very variable since there are countries that differ up to two orders of magnitude.

Objective: To analyze the positive/deaths ratio up to May 24, 2021, in the European countries on the light of asymptomatic subjects and determine if the presence of non-mortal drifts can justify the present deaths decay.

Methods: The data of the European countries were retrieved from the WHO coronavirus dashboard. Italy was taken as example to calculate the differences among regions in the same country, and the relative data were taken from the Official Bulletin. Statistical analysis was based on the ODDS ratio.

Results: True asymptomatic subjects are difficult to be calculated and the differences among the deaths ratio can be due to the presence of non-mortal drifts.

Conclusions: The non-mortal drift should be considered as one of the reasons of the present death decay, and vaccinations can accelerate this process.

References

  1. V’kovski P, Kratzei A, Steiner S et al. Coronavirus biology and replication: implication for SARS-Cov-2. Nature Microbiology 2021; 19: 155-169.
     Google Scholar
  2. Morens DM, Brema JC, Calisher CH et al. The origin of COVID-19 and why it matters. Am J Trop Med Hyg 2020; 103(3): 955-959.
     Google Scholar
  3. Cheng VCC, Lau SKP, Woo PCY, Yuen KY. Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clin Microb Rev 2007: 2(4): 660-694.
     Google Scholar
  4. Alagalli AN, Briese T, Mishra N et al. Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia. mBio 5:e00884-14-e00814. http://doi.org/10.1128/mBio.00884-14.
     Google Scholar
  5. Ithete NL, Stroffberg S, Coman VM et al. Close relative of human Middle East respiratory syndrome coronavirus in bat. South Africa Emerg Infect Dia 2013,19: 1697-1699.
     Google Scholar
  6. Woo PC, lau SK, Yip CC et al. Comparative analysis of 22 coronavirus HKU1 genomes reveals a novel genotype and evidence of natural recombination in coronavirus HKU1. J Virol 2006; 80: 7136-7145.
     Google Scholar
  7. Zhu N, Zhang D, Wang W et al. A novel coronavirus from patients with pneumonia in China, 2019. NEJM 2019: 382: 727-733.
     Google Scholar
  8. Cao S, Gan Y, Wang C et al. Post-lockdown SARS-Cov-2 nucleic acid screening in nearly 10 million resident of Wuhan, China. Nat Commun 2020; https://doi.org/10.1038/s41467-020-19802-w.
     Google Scholar
  9. Pollock AM, Lancaster J. Asymptomatic transmission of covid-19. BMJ 2020; 371: m4851http://dx.doi.org/10.1136/bmj.m4851.
     Google Scholar
  10. Bultrago-Garcia D, Egil-Gany D, Counotte MJ et al. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-Cov-2 infection: a living systematic review and meta-analysis. Plos Medicine 2020 http://doi.org/10.1371/8journal.pmed.1003346.
     Google Scholar
  11. Zhou X, Li Y, Li T, Zhang W. Follow-up of asymptomatic patients with SARS-CoV-2 infection. Clin Microb Infect 2020; 26:957-959.
     Google Scholar
  12. Chen G, Wu D, Guo W et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest 2020;130(5): 2620-2629.
     Google Scholar
  13. Stephenson E, Reynolds G, Botting RA et al. Single-cell multi-omics analysis of the immune response in COVID-19. Nature Medicine 2021;27: 904-914.
     Google Scholar
  14. Long QX, Tang KJ, Shi QL et al. Clinical immunological assessment of asymptomatic SARS-Cov-2 infection. Nature Medicine 2020;26: 1200-1204.
     Google Scholar
  15. Yu C, Zhou M, Liu Y et al. Characteristics of asymptomatic COVID-19 infection and progression: a multicenter, retrospective study. Virulence 2020; 11. 1006-1014.
     Google Scholar
  16. Tauemberg JK, Morens DM. Pandemic influenza-including a risk assessment of H5N1. Rev Sci Tech 2009; 28: 187-202.
     Google Scholar
  17. Johnson NP, Mueller J. Updating the accounts: global mortality of the 1918-1920 “Spanish” influenza pandemic. Bulletin of the history of medicine. 2002; 76: 105-115.
     Google Scholar
  18. World Health Organization WHO Dashboard http://covid 19 who.int.
     Google Scholar
  19. Bollettino Coronavirus protezione Civile https://www.lavoripubblici.it/news/ultime-notizie-covid-19-bollettino-protezione-civile-24-maggio-2021-html.
     Google Scholar
  20. Cornelli U, Belcaro G, Recchia M. COVID-19 vaccination: hopes and facts to cover incompetence. J Bacteriol & Parasitol 2021; 12(3):1-22.
     Google Scholar
  21. Cornelli U, Belcaro G, Cesarone MR, Recchia M, Cotellese R. Cov19 in Italy: correlation with Clinical, demographical, social variables and water. JMCRR 2020; 4(6): 1-10.
     Google Scholar
  22. Ziegler CG, CaoY, Guo Z et al. SARS-Cov-2 receptor is an interferon-stimulated gene in human airways epithelial cells and is detected in specific cell subsets across tissues. Cell 2020;181:1-20.
     Google Scholar
  23. Shang J, Wan Y, Luo C et al. Cell entry mechanisms o SARRS-CoV-2PNAS 2020;117: 117241-11734.
     Google Scholar
  24. Duffy S. Why are RNA virus mutation so damn high? PLOS biology 2018;16(8): e3000003.https//doi. Org.10.137/jpurnal.pbio.3000003.
     Google Scholar
  25. Vignuzzi M, Andino R. Closing the gap: the challenges in convering theoretical, computational, experimental and real-life studies in virus evolution. Curr Opin Virol 2012; 2(5): 515-518.
     Google Scholar
  26. Cornelli U, Belcaro G. The effect of COVID-19 vaccination in 47 European countries. EJMED (in press).
     Google Scholar
  27. Wu A, Peng Y, Huang B et Al. Genome composition and divergence of the novel coronavirus (2019-nCov) originating in China. Cell Host & Micr 2020 https//doi.org10.1016/j.chom2020.02.001.
     Google Scholar
  28. Cornelli U, Belcaro G, Martino R. The many waves of COVID-19 in European Countries. 2021 Lampert Academic Publishing.
     Google Scholar


Most read articles by the same author(s)